Olivier Gouédard
Direttore operativo presso Cytovia Therapeutics, Inc.
Posizioni attive di Olivier Gouédard
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Direttore operativo | 22/06/2021 | - |
Storia della carriera di Olivier Gouédard
Formazione di Olivier Gouédard
| New York University | Masters Business Admin |
| Université Paris-Saclay | Undergraduate Degree |
| University of Rennes | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Francia | 3 |
Posizioni
| Chief Operating Officer | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Olivier Gouédard
- Esperienza
